Assyro AI

FDA PDUFA dates in November 2026

Published PDUFA target action dates for NDAs, BLAs, ANDAs, and INDs scheduled in November 2026, sourced from FDA primary records.

Tracking 3 published FDA PDUFA decisions, including 1 NDA and 2 BLAs.

FDA PDUFA dates in November 2026: 3 published FDA PDUFA target action dates.
SponsorProductTypeApplicationPDUFA dateStatus
BioXcel TherapeuticsIGALMINDAPENDING-provisional|bioxceltherapeutics|igalmi|acutetreaupcoming
Summit Therapeuticsivonescimab + chemotherapyBLAPENDING-provisional|summittherapeutics|ivonescimabchemotupcoming
SavaramolgramostimBLAPENDING-provisional|savara|molgramostim|autoimmunepulmonupcoming

Use the calendar, timeline, status board, or table views above to filter, sort, and inspect source-linked details.

November 2026 FDA PDUFA Calendar: Drug Approval Dates & Deadlines

Track November 2026 FDA PDUFA dates for NDA, BLA, ANDA, and IND decisions. Free drug approval tracker with source-linked deadlines, calendar views, and daily updates.